• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURAVI LTD. UNK_THROMBECTOMY NEURAVI; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURAVI LTD. UNK_THROMBECTOMY NEURAVI; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number UNK_THROMBECTOMY NEURAVI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Infarction, Cerebral (1771); No Code Available (3191)
Event Date 03/31/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Cerenovus manufacturer's report numbers: 3011370111-2020-00002, 3011370111-2020-00004, and 3011370111-2020-00005 are related to the same incident.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿intracranial stenting after failure of thrombectomy with the embotrap® device¿ (pmid: 29845367).12 patients with acute stroke caused by large vessel occlusions and treated with the embotrap® device experienced re-occlusion and cerebral infarction.The patients were treated with intracranial stenting.Background: primary permanent intracranial stenting was initially used in the era before thrombectomy and might still be a useful rescue treatment in acute stroke patients suffering from ongoing large vessel occlusion refractory to thrombectomy.Methods: the prospectively collected registry of patients with acute stroke caused by large vessel occlusions and treated with the embotrap® device in (b)(6) hospital from october 2013 through march 2017 were retrospectively reviewed.Clinical outcome of non-recanalized patients with thrombolysis in cerebral infarction (tici) score of 0¿1 after failed thrombectomy were compared with those who were treated with permanent intracranial stenting as rescue therapy.Favorable outcome was defined as a modified rankin scale 0¿2.The embotrap® device was used in 201 patients.No device-specific information (including catalog and lot number) were provided in the article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_THROMBECTOMY NEURAVI
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
NEURAVI LTD.
see h10
galway H91 K 5YD
EI  H91 K5YD
Manufacturer (Section G)
ADVANT MEDICAL
parkmore business park west
galway H91 P V0V
EI   H91 PV0V
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9570926
MDR Text Key189451116
Report Number3011370111-2020-00003
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_THROMBECTOMY NEURAVI
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/17/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-